Vumerity for Multiple Sclerosis During Pregnancy
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Recruiting
Observational Study
Multiple Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Female
- Study type
- Observational
- Participants needed
- 908 (estimated)
- Sponsor
- Biogen · Industry
Who this trial is looking for
This trial is looking for women with multiple sclerosis who are pregnant or planning to become pregnant. Participants will share information about their use of Vumerity and other treatments during their pregnancy.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with multiple sclerosis.
- I used Vumerity during my pregnancy or stopped other treatments before pregnancy.
- I know the outcome of my pregnancy.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The primary objectives of the study are to estimate the risk of major congenital malformations (MCMs) in infants born to women with multiple sclerosis (MS) who were exposed to diroximel fumarate (DRF) at any time from 2 weeks after the first day of their last menstrual period (LMP) up through the first trimester of pregnancy and to comparatively evaluate pregnancy outcomes with MCMs in women with …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion Criteria:
* Participant must have a diagnosis of MS
* Documentation that the participant was one of the following:
1. exposed to DRF at any time from 2 weeks after the first day of their LMP (i.e., conception date) up through any time during pregnancy. (If exact exposure dates are …
Contacts